FDA triples death toll linked to heparin
to 62
The Food and Drug Administration has tripled the number of deaths it attributes
to side effects of the blood thinner heparin, which triggered a huge recall earlier
this year.
The agency has been investigating contamination of heparin made by Baxter International
Inc., which it linked to 19 deaths and hundreds of allergic reactions.
After reviewing adverse events back to January 2007, the FDA said Tuesday it
uncovered 103 reports of patients who died while taking heparin.
Of those deaths, 62 involved allergic reactions or hypotension, a type of dangerously
low blood pressure. Those are the same side effects that caused Baxter to pull
all U.S. heparin injections from the market by February.
The agency's month-by-month figures include deaths of patients taking heparin
made by various manufacturers, not just Baxter.
The FDA received 55 reports of death with the blood thinner in 2006, but only
three were due to allergic reactions.
FDA spokeswoman Karen Riley said the agency decided to release the additional
numbers on heparin deaths at the request of consumers. Previous agency announcements
were limited to adverse events recorded in 2008.
Riley said the drug has long carried warnings of low blood pressure risks, which
probably contributed to deaths seen in prior years.
A Baxter spokeswoman said the Deerfield, Ill.-based company has identified only
four deaths to date where its recalled heparin may have played a role. The FDA's
numbers include reports from additional sources, including other manufacturers.
Another manufacturer, APP Pharmaceuticals Inc., said there have been no reports
of death with its product due to the allergic reactions cited
by the FDA. The agency found no contamination in heparin batches made by the
Schaumburg, Ill.-based company.
Heparin is derived from a mucus obtained from pig intestines and other animal
tissues, often processed by small, unregistered workshops in China.
The FDA determined last month that Baxter's drug was contaminated with an unnatural
chemical during production at a plant in China. The agency is still investigating
whether the chemical was added accidentally or deliberately.
This article appeared on page A - 5 of the San Francisco Chronicle
For more information on current recalls and product
safety, visit the FDA
recall alert web page. |